Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation

The Journal of Clinical Investigation
H CuppensJ J Cassiman

Abstract

In congenital bilateral absence of the vas deferens patients, the T5 allele at the polymorphic Tn locus in the CFTR (cystic fibrosis transmembrane conductance regulator) gene is a frequent disease mutation with incomplete penetrance. This T5 allele will result in a high proportion of CFTR transcripts that lack exon 9, whose translation products will not contribute to apical chloride channel activity. Besides the polymorphic Tn locus, more than 120 polymorphisms have been described in the CFTR gene. We hypothesized that the combination of particular alleles at several polymorphic loci might result in less functional or even insufficient CFTR protein. Analysis of three polymorphic loci with frequent alleles in the general population showed that, in addition to the known effect of the Tn locus, the quantity and quality of CFTR transcripts and/or proteins was affected by two other polymorphic loci: (TG)m and M470V. On a T7 background, the (TG)11 allele gave a 2.8-fold increase in the proportion of CFTR transcripts that lacked exon 9, and (TG)12 gave a sixfold increase, compared with the (TG)10 allele. T5 CFTR genes derived from patients were found to carry a high number of TG repeats, while T5 CFTR genes derived from healthy CF fat...Continue Reading

References

Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·B C TrapnellR G Crystal
Jan 1, 1989·Archives of Oto-rhino-laryngology·M JorissenJ J Cassiman
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J DavignonC F Sing
Apr 1, 1994·Human Molecular Genetics·H CuppensJ J Cassiman
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·S B FulmerG R Cutting
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A Todd
Jun 1, 1995·The New England Journal of Medicine·M ChillónM Claustres
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·L MonariB Ghetti
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses

❮ Previous
Next ❯

Citations

Jan 24, 2007·Journal of Gastroenterology·Satoru NaruseHiroshi Ishiguro
Mar 25, 2005·Journal of Genetic Counseling·Elinor Langfelder-SchwindUNKNOWN National Society of Genetic Counselors Subcommittee on Cystic Fibrosis Carrier Testing
May 29, 2008·Clinical Reviews in Allergy & Immunology·Karen Z Voter, Clement L Ren
Feb 16, 1999·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B F ThielemansE Legius
Jul 12, 2008·Reproductive Biomedicine Online·L TamburinoS Chamayou
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Anne VankeerberghenJean-Jacques Cassiman
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Chieko AnzaiKunihiko Yoshimura
Jun 17, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·C BombieriC Ferec
Feb 11, 2000·Clinical Genetics·C ArduinoE Gaia
Aug 19, 2010·European Journal of Human Genetics : EJHG·Céline RenéMarie des Georges
Mar 17, 1999·British Journal of Pharmacology·C MaertensB Nilius
May 5, 2005·European Journal of Human Genetics : EJHG·Liborio StuppiaBruno Dallapiccola
Oct 28, 2005·European Journal of Human Genetics : EJHG·Fiorenza PompeiPier Franco Pignatti
Apr 28, 2006·European Journal of Human Genetics : EJHG·David Haig
Oct 7, 2006·European Journal of Human Genetics : EJHG·André SchallerSabina Gallati
Aug 28, 2003·Annals of Human Genetics·Rebecca K Rowntree, Ann Harris
Feb 6, 2004·The New England Journal of Medicine·Steven D FreedmanBrian P O'Sullivan
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Timothy W HefferonGarry R Cutting
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Bénédicte DuriezSerge Amselem
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Fredrick Van GoorPaul Negulescu
Jul 26, 2008·Genetic Testing·Marija StankovicDragica Radojkovic
Apr 14, 2010·Human Gene Therapy·Lucia RocchiDirk Schindelhauer
Jul 16, 2010·Nucleic Acids Research·Gwendal DujardinLaurent Corcos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.